IL27 and prostate cancer: Di Carlo et al. reported that IL-27 inhibits prostate cancer cell proliferation and modulates the expression of genes involved in the angiogenic process such as fms-related tyrosine kinase, fibroblast growth factor receptor, CXCL10, and TIMP382.